Article
Pharmacogenomics and schizophrenia.
European journal of pharmacology - 27 Dec 2000
Kawanishi Y, Tachikawa H, Suzuki T
Abstract excerpt
Although antipsychotic drugs are effective in alleviating schizophrenic symptoms, individual differences in patient response suggest that genetic components play a major role, and pharmacogenetic studies have indicated the possibility for a more individually based pharmacotherapy. The new field of pharmacogenomics, which focuses on genetic determinants of drug response at the level of the entire human genome, is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
